FindTrial
Sign In

Safety and effectiveness of high power quantitative ablation for atrial fibrillation: a single-center real-world study

Safety and effectiveness of high power quantitative ablation for atrial fibrillation: a single-center real-world study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900024224
Enrollment
Unknown
Registered
2019-07-01
Start date
2019-07-01
Completion date
Unknown
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

Experimental group:High power atrial fibrillation ablation

Sponsors

First Affiliated Hospital of China University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Willing to undergo radiofrequency catheter ablation of atrial fibrillation; 2. Aged 18 years and above.

Exclusion criteria

Exclusion criteria: Researchers believe that other reasons are not suitable for subjects to continue clinical practice.

Design outcomes

Primary

MeasureTime frame
Immediate success rate after ablation of atrial fibrillation;Adverse events during and 3 months after operation;Proportion of atrial fibrillation within 3/6/9 months after surgery;—

Secondary

MeasureTime frame
Ablation time, operation time and X-ray fluoroscopy time;—

Countries

China

Contacts

Public ContactJian Xu

The First Affiliated Hospital of China University of Science and Technology

4955255@qq.com+86 13905515819

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026